PRIMARY BILIARY CIRRHOSIS
Clinical trials for PRIMARY BILIARY CIRRHOSIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CIRRHOSIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CIRRHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for PBC patients: Long-Term safety trial of seladelpar underway
Disease control OngoingThis study tests the long-term safety of a drug called seladelpar in people with primary biliary cholangitis (PBC), a chronic liver disease. About 340 adults who previously took seladelpar in another PBC study will continue taking it and be monitored for side effects. The goal is…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for rare liver disease: drug shows promise in Late-Stage trial
Disease control OngoingThis study tests a new drug called elafibranor for people with primary biliary cholangitis (PBC), a rare liver disease that can lead to scarring and liver failure. The trial includes 161 adults who did not get better with or could not take the standard medicine. The goal is to se…
Matched conditions: PRIMARY BILIARY CIRRHOSIS
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated May 13, 2026 15:59 UTC